KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in CashDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Thermo Fisher Scientific (TMO) Change in Inventory (2016 - 2020)

Historic Change in Inventory for Thermo Fisher Scientific (TMO) over the last 12 years, with Q4 2020 value amounting to $81.0 million.

  • Thermo Fisher Scientific's Change in Inventory rose 80000.0% to $81.0 million in Q4 2020 from the same period last year, while for Dec 2020 it was $508.0 million, marking a year-over-year increase of 1091.7%. This contributed to the annual value of $27.0 million for FY2024, which is 10451.51% up from last year.
  • Thermo Fisher Scientific's Change in Inventory amounted to $81.0 million in Q4 2020, which was up 80000.0% from $118.0 million recorded in Q3 2020.
  • Thermo Fisher Scientific's Change in Inventory's 5-year high stood at $176.0 million during Q3 2019, with a 5-year trough of -$127.0 million in Q4 2017.
  • Over the past 5 years, Thermo Fisher Scientific's median Change in Inventory value was $76.0 million (recorded in 2018), while the average stood at $63.6 million.
  • As far as peak fluctuations go, Thermo Fisher Scientific's Change in Inventory plummeted by 19060.15% in 2016, and later surged by 80000.0% in 2020.
  • Quarter analysis of 5 years shows Thermo Fisher Scientific's Change in Inventory stood at -$75.7 million in 2016, then tumbled by 67.77% to -$127.0 million in 2017, then surged by 92.91% to -$9.0 million in 2018, then soared by 200.0% to $9.0 million in 2019, then skyrocketed by 800.0% to $81.0 million in 2020.
  • Its Change in Inventory was $81.0 million in Q4 2020, compared to $118.0 million in Q3 2020 and $168.0 million in Q2 2020.